Search research articles
Contact Us
Filters
Showing results (721-730 of 742) with videos related to
Page
of 75
Sort By:
Science Translational Medicine
|
April 5, 2013
Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells
Emre Ozkumur, Ajay M Shah, Jordan C Ciciliano, et al.
NPJ Precision Oncology
|
March 2, 2022
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial
A S Mansfield, Z Wei, R Mehra, et al.
Cancer Discovery
|
February 28, 2018
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts
Benjamin J Drapkin, Julie George, Camilla L Christensen, et al.
Antimicrobial Agents and Chemotherapy
|
October 13, 2020
Comparison of Proteomic Responses as Global Approach to Antibiotic Mechanism of Action Elucidation
Christoph H R Senges, Jennifer J Stepanek, Michaela Wenzel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2011
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice
L V Sequist, R S Heist, A T Shaw, et al.
The New England Journal of Medicine
|
October 29, 2010
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
Eunice L Kwak, Yung-Jue Bang, D Ross Camidge, et al.
Cancer Discovery
|
February 11, 2017
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
Alexander Drilon, Salvatore Siena, Sai-Hong Ignatius Ou, et al.
The Lancet. Oncology
|
December 16, 2019
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials
Alexander Drilon, Salvatore Siena, Rafal Dziadziuszko, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|
December 6, 2021
Isotopic signatures of methane emissions from tropical fires, agriculture and wetlands: the MOYA and ZWAMPS flights
, Euan G Nisbet, Grant Allen, et al.
The Lancet. Oncology
|
December 16, 2019
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
Robert C Doebele, Alexander Drilon, Luis Paz-Ares, et al.
Page
of 75
Search research articles
Search
Showing results (721-730 of 742) with videos related to
Sort By:
Page
of 75
Science Translational Medicine
|
April 5, 2013
Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells
Emre Ozkumur, Ajay M Shah, Jordan C Ciciliano, et al.
NPJ Precision Oncology
|
March 2, 2022
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial
A S Mansfield, Z Wei, R Mehra, et al.
Cancer Discovery
|
February 28, 2018
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts
Benjamin J Drapkin, Julie George, Camilla L Christensen, et al.
Antimicrobial Agents and Chemotherapy
|
October 13, 2020
Comparison of Proteomic Responses as Global Approach to Antibiotic Mechanism of Action Elucidation
Christoph H R Senges, Jennifer J Stepanek, Michaela Wenzel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2011
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice
L V Sequist, R S Heist, A T Shaw, et al.
The New England Journal of Medicine
|
October 29, 2010
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
Eunice L Kwak, Yung-Jue Bang, D Ross Camidge, et al.
Cancer Discovery
|
February 11, 2017
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
Alexander Drilon, Salvatore Siena, Sai-Hong Ignatius Ou, et al.
The Lancet. Oncology
|
December 16, 2019
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials
Alexander Drilon, Salvatore Siena, Rafal Dziadziuszko, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|
December 6, 2021
Isotopic signatures of methane emissions from tropical fires, agriculture and wetlands: the MOYA and ZWAMPS flights
, Euan G Nisbet, Grant Allen, et al.
The Lancet. Oncology
|
December 16, 2019
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
Robert C Doebele, Alexander Drilon, Luis Paz-Ares, et al.
Page
of 75